H. LUNDBECK AS
914022940ActiveGlobal pharmaceutical company specializing exclusively in brain disease treatments and research.
Pharmaceutical Companylundbeck.com
Yleiskatsaus
- 9
- Työntekijät
- 63.6milj NOK
- Liikevaihto
- 1948
- Perustettu
Avainpäättäjät
Karin Hamberg
Chief Medical Officer
@lundbeck.com
Joerg Hornstein
CFO and Executive Vice President, Corporate Functions
@lundbeck.com
Thomas Gibbs
Executive Vice President, Head of Lundbeck U.S.
@lundbeck.com
Tarek Samad
Senior Vice President & Global Head of Research, Corporate Patents & Trademarks
@lundbeck.com
+11 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Lundbeck is a specialized global pharmaceutical company dedicated exclusively to brain diseases. For over 70 years, the organization has focused intensely on neuroscience research, development, manufacturing, and commercialization of treatments. Their core purpose is advancing brain health and trans...
Angelini Pharma Nordics AB